(Q37853050)

24 August 2017

1 reference

title

Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome (English)

1 reference

24 August 2017

Roberta Gualtierotti

1

0 references

Pier Luigi Meroni

object named as

Pier Luigi Meroni

series ordinal

3

0 references

Martina Biggioggero

series ordinal

2

object named as

Martina Biggioggero

1 reference

24 August 2017

1 February 2013

1 reference

Clinical Reviews in Allergy & Immunology

24 August 2017

1 reference

24 August 2017

44

1 reference

24 August 2017

1

1 reference

24 August 2017

51-56

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-011-8268-9

24 August 2017

0 references

cites work

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Arterial thrombosis and the role of thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Cardiac manifestations in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Clinical factors and angiographic features associated with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Myocardial infarction in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Acute myocardial infarction in young adults: causes and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Morbidity and mortality in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Current concepts on the pathogenesis of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Infectious origin of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Unusual manifestations of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Insights into atherosclerosis therapy in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Subclinical atherosclerosis in primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Acute myocardial infarction in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Management of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

The treatment of antiphospholipid syndrome: a harmonic contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Patients with antiphospholipid syndrome display endothelial perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8268-9

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

21 January 2018

1 reference

12 December 2020

Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome

1 reference

12 December 2020

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women

1 reference

12 December 2020

Antiphospholipid antibodies in acute coronary syndrome

1 reference

12 December 2020

Antiphospholipid antibodies and myocardial infarction

1 reference

12 December 2020

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program

1 reference

12 December 2020

Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA.

1 reference

12 December 2020

The presence of antiphospholipid antibodies in acute myocardial infarction

1 reference

12 December 2020

Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome

1 reference

12 December 2020

Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women

1 reference

12 December 2020

Myocardial infarction in young adults: risk factors and clinical features

1 reference

12 December 2020

Are antiphospholipid antibodies an independent risk factor for atherosclerosis?

1 reference

12 December 2020

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

1 reference

12 December 2020

Myocardial infarction in the young and in women.

1 reference

12 December 2020

Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding

1 reference

12 December 2020

10.1007/S12016-011-8268-9

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21403998